Search hospitals > California > Stanford
Stanford Hospital and Clinics
Claim this profileStanford, California 94305
Global Leader in Breast Cancer
Global Leader in Cancer
Conducts research for Leukemia
Conducts research for Lymphoma
Conducts research for Acute Lymphoblastic Leukemia
179 reported clinical trials
21 medical researchers
Summary
Stanford Hospital and Clinics is a medical facility located in Stanford, California. This center is recognized for care of Breast Cancer, Cancer, Leukemia, Lymphoma, Acute Lymphoblastic Leukemia and other specialties. Stanford Hospital and Clinics is involved with conducting 179 clinical trials across 426 conditions. There are 21 research doctors associated with this hospital, such as Andrei Iagaru, MD, David P. Lee, MD, Seema Nagpal, MD, and Kristen Ganjoo, M.D..Area of expertise
1Breast Cancer
Global LeaderHER2 negative
ER positive
Stage IV
2Cancer
Global LeaderNY-ESO-1 positive
HLA-A positive
HLA positive
Top PIs
Andrei Iagaru, MDStanford University1 year of reported clinical research
Studies Prostate Cancer
Studies Pancreatic Cancer
15 reported clinical trials
21 drugs studied
David P. Lee, MDStanford Hospital and Clinics7 years of reported clinical research
Studies Cardiovascular Disease
Studies Hypertension
10 reported clinical trials
15 drugs studied
Seema Nagpal, MDStanford Cancer Institute3 years of reported clinical research
Studies Glioblastoma
Studies Lung Cancer
10 reported clinical trials
13 drugs studied
Kristen Ganjoo, M.D.Stanford University5 years of reported clinical research
Studies Synovial Sarcoma
Studies Round Cell Liposarcoma
9 reported clinical trials
16 drugs studied
Clinical Trials running at Stanford Hospital and Clinics
Breast Cancer
Lung Cancer
Parathyroid Adenomas
Stomach Cancer
Solid Tumors
Abdominal Aortic Aneurysm
Parkinson's disease
Parotid Gland Cancer
Non-Small Cell Lung Cancer
Heart Disease
Sacituzumab Tirumotecan + Pembrolizumab
for Breast Cancer
The purpose of this study is to compare sacituzumab tirumotecan as a single agent, and in combination with pembrolizumab, versus Treatment of Physician's Choice (TPC) in participants with hormone receptor positive/human epidermal growth factor receptor-2 negative (HR+/HER2-) unresectable locally advanced, or metastatic, breast cancer. The primary hypotheses are that sacituzumab tirumotecan as a single agent and sacituzumab tirumotecan plus pembrolizumab are superior to TPC with respect to progression-free survival (PFS) per Response Evaluation Criteria in Solid Tumors version 1.1 (RECIST 1.1) by blinded independent central review (BICR) in all participants.
Recruiting2 awards Phase 33 criteria
Sacituzumab Govitecan + Pembrolizumab
for Triple Negative Breast Cancer
The goal of this study is to find out if the experimental product, sacituzumab govitecan-hziy (SG) in combination with pembrolizumab given after surgery, is effective and safe compared to the treatment of physician's choice (TPC) which includes either pembrolizumab or pembrolizumab plus capecitabine in participants with triple negative breast cancer that still remains after surgery and pre-surgical treatment.
Recruiting2 awards Phase 36 criteria
T-DM1 vs TH
for Breast Cancer
This research study is studying how well newly diagnosed breast cancer that has tested positive for a protein called HER2 responds using one of two different combination of HER2-directed therapies as a treatment after surgery. The name of the study drugs involved are: * Trastuzumab-emtansine (T-DM1, Kadcyla) * Trastuzumab SC (Herceptin Hylecta) * Paclitaxel
Recruiting1 award Phase 2
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Stanford Hospital and Clinics?
Stanford Hospital and Clinics is a medical facility located in Stanford, California. This center is recognized for care of Breast Cancer, Cancer, Leukemia, Lymphoma, Acute Lymphoblastic Leukemia and other specialties. Stanford Hospital and Clinics is involved with conducting 179 clinical trials across 426 conditions. There are 21 research doctors associated with this hospital, such as Andrei Iagaru, MD, David P. Lee, MD, Seema Nagpal, MD, and Kristen Ganjoo, M.D..
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.